We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

WuXi Opening Offices in Boston and San Francisco

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

WuXi PharmaTech (Cayman) Inc. has announced that it will open offices in Boston and San Francisco in early 2015. These new offices will give the company greater access to innovative companies in the world's two leading biotech hubs, both as customers and as investments.

In October, WuXi has announced that it had opened an office in Israel to tap into the biotech community there. In addition, the company has U.S. facilities in St. Paul, Philadelphia, Atlanta, Plainsboro (NJ), and San Diego.

"Our vision is to enable anyone and any company to discover and develop healthcare products to benefit the world's patients," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "These new offices bring our comprehensive platform of integrated R&D services closer to where entrepreneurs are and where cutting-edge science is being done."